デフォルト表紙
市場調査レポート
商品コード
1493291

美容注射剤の市場規模、シェア、動向分析レポート:製品別、用途別、最終用途別、地域別、セグメント別予測、2024年~2030年

Aesthetic Injectable Market Size, Share & Trends Analysis Report By Product (Hyaluronic Acid, Aquatic Light Injections), By Application (Facial Line Correction, Lip Augmentation), By End-use, By Region, And Segment Forecasts, 2024 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 143 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.14円
美容注射剤の市場規模、シェア、動向分析レポート:製品別、用途別、最終用途別、地域別、セグメント別予測、2024年~2030年
出版日: 2024年05月22日
発行: Grand View Research
ページ情報: 英文 143 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

美容注射剤市場の成長と動向:

Grand View Research, Inc.の新しいレポートによると、世界の美容注射剤市場規模は2024年から2030年にかけて12.1%のCAGRを記録し、2030年までに241億3,000万米ドルに達すると予測されています。

この業界は、いくつかの要因によって顕著な成長を遂げています。これらには、低侵襲美容処置に対する消費者の意識の高まり、注射技術の進歩、非外科的美容強化に対する需要の高まりが含まれます。

技術や研究の進歩は、独創的な注射製剤の開発につながり、小じわ、シワ、体積減少、肌の質感など、的確な悩みに対応する様々な製品を含む市場の提供を拡大しています。例えば、2024年1月の国立生物工学情報センター(NCBI)によると、注射可能なSculptra Poly-L-Lactic Acid(PLLA-SCA)治療は好評で、肌質を向上させながら、中程度から重度のシワや頬のシワの重症度を顕著に減少させました。その効果は12ヶ月の試験期間中一貫しており、被験者は高い満足度を報告し、自然な外観を獲得し、さらなる治療を熱望しました。

さらに、美容基準の変化と高齢化人口の増加が市場の拡大に寄与しています。さらに、主要企業による革新的なマーケティング戦略と相まって、幅広い種類の注射剤が入手可能であることが、市場の成長をさらに刺激しています。さらに、有利な規制の枠組みや美容クリニックと医療スパのネットワークの拡大が、世界中で美容注射剤の取り込みを促進しています。

美容注射剤市場レポートハイライト

  • 製品別に見ると、ボツリヌス毒素(ボトックス)セグメントは、顔のしわや小じわを目立たなくするために一時的に使用されるため、2023年に45.8%の最大収益シェアを占めました。
  • ヒアルロン酸(HA)セグメントは、肌の保湿、ボリューム、弾力性を高め、より滑らかで若々しい外観をもたらすという利点があるため、予測期間中に12.7%のCAGRで最も速い成長が見込まれています。
  • 最終用途に基づくと、医療スパ部門は2023年に46.9%の最大の収益シェアを占め、予測期間中に12.3%の最速CAGRで成長すると予測されています。医療スパは、リラックスできる贅沢な環境で注射治療を含む様々な美容施術を提供することで、美容注射剤市場の成長に貢献しています。
  • 用途別では、顔の若返りのための小じわ、シワ、容積減少など様々な悩みに対応することから、2023年にはフェイスライン矯正分野が33.4%の最大収益シェアを占め、予測期間中CAGR 12.5%の急成長が見込まれています。
  • 2023年には、北米が化粧品強化製品への絶え間ない需要により39.3%のシェアを占め、アジア太平洋は技術革新の拠点であり、美容注射剤や技術の継続的な進歩により、予測期間中に15.8%の最速CAGRで成長すると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 美容注射剤市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場牽引要因分析
    • 市場抑制要因分析
  • 美容注射剤市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 美容注射剤市場:製品推定・動向分析

  • 製品市場シェア、2023年および2030年
  • セグメントダッシュボード
  • 美容注射剤市場:製品別展望
  • 2018年から2030年までの市場規模と予測および動向分析
  • ヒアルロン酸
  • ボツリヌス菌
  • 水光注射

第5章 美容注射剤市場: 最終用途の推定・動向分析

  • 最終用途市場シェア、2023年および2030年
  • セグメントダッシュボード
  • 最終用途別美容注射剤市場展望
  • 2018年から2030年までの市場規模と予測および動向分析
  • メディカルスパ
  • 皮膚科クリニック
  • 病院

第6章 美容注射剤市場:用途の推定・動向分析

  • 用途市場シェア、2023年および2030年
  • セグメントダッシュボード
  • 美容注射剤市場:用途別展望
  • 2018年から2030年までの市場規模と予測および動向分析
  • 輪郭修正
  • 口唇拡大
  • フェイスリフト
  • ニキビ跡治療
  • 脂肪萎縮治療

第7章 競合情勢

  • 企業/競合の分類
  • 企業プロファイル
    • Ipsen Pharma
    • AbbVie, Inc.
    • Merz GmbH and Co. KGaA
    • Galderma
    • Prollenium Medical Technologies, Inc.
    • Suneva Medical, Inc.
    • Sinclair Pharma
    • Medytox, Inc.
    • Revance Therapeutics, Inc.
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America aesthetic injectable market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 5 North America aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 8 U.S. aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 9 Canada aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 12 Europe aesthetic injectable market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 14 Europe aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 16 UK aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 17 UK aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 18 UK aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 19 Germany aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 20 Germany aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 21 Germany aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 22 France aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 23 France aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 24 France aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 25 Italy aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Italy aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 28 Spain aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Spain aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 31 Denmark aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 32 Denmark aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Denmark aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 34 Sweden aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 35 Sweden aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Sweden aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 37 Norway aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 38 Norway aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Norway aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific aesthetic injectable market, by region, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 44 Japan aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 45 Japan aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 46 Japan aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 47 China aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 48 China aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 49 China aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 50 India aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 51 India aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 52 India aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 53 Australia aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 54 Australia aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Australia aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 56 South Korea aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 57 South Korea aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 58 South Korea aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 59 Thailand aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 60 Thailand aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Thailand aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 62 Latin America aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 63 Latin America aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 64 Latin America aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 65 Brazil aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 66 Brazil aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 67 Brazil aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 68 Mexico aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 69 Mexico aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 70 Mexico aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 71 Argentina aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 72 Argentina aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Argentina aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 74 MEA aesthetic injectable market, by region, 2018 - 2030 (USD Million)
  • Table 75 MEA aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 76 MEA aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 77 MEA aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 78 South Africa aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 79 South Africa aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 80 South Africa aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 84 UAE aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 85 UAE aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 86 UAE aesthetic injectable market, by application, 2018 - 2030 (USD Million)
  • Table 87 Kuwait aesthetic injectable market, by product, 2018 - 2030 (USD Million)
  • Table 88 Kuwait aesthetic injectable market, by end use, 2018 - 2030 (USD Million)
  • Table 89 Kuwait aesthetic injectable market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Aesthetic injectable market: outlook
  • Fig. 9 Aesthetic injectable competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Aesthetic injectable market driver impact
  • Fig. 15 Aesthetic injectable market restraint impact
  • Fig. 16 Aesthetic injectable market strategic initiatives analysis
  • Fig. 17 Aesthetic injectable market: Product movement analysis
  • Fig. 18 Aesthetic injectable market: Product outlook and key takeaways
  • Fig. 19 Hyaluronic Acid (HA) market estimates and forecast, 2018 - 2030
  • Fig. 20 Botulinum Toxin (Botox) market estimates and forecast, 2018 - 2030
  • Fig. 21 Aquatic light injections market estimates and forecast, 2018 - 2030
  • Fig. 22 Others market estimates and forecast, 2018 - 2030
  • Fig. 23 Aesthetic injectable market: End use movement analysis
  • Fig. 24 Aesthetic injectable market: End use outlook and key takeaways
  • Fig. 25 Medical Spas market estimates and forecasts, 2018 - 2030
  • Fig. 26 Dermatology Clinics market estimates and forecasts,2018 - 2030
  • Fig. 27 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 28 Aesthetic injectable market: Application movement analysis
  • Fig. 29 Aesthetic injectable market: Application outlook and key takeaways
  • Fig. 30 Facial Line Correction market estimates and forecast, 2018 - 2030
  • Fig. 31 Lip Augmentation market estimates and forecast, 2018 - 2030
  • Fig. 32 Face Lift market estimates and forecast, 2018 - 2030
  • Fig. 33 Acne Scar Treatment market estimates and forecast, 2018 - 2030
  • Fig. 34 Lipoatrophy Treatment market estimates and forecast, 2018 - 2030
  • Fig. 35 Others market estimates and forecast, 2018 - 2030
  • Fig. 36 Aesthetic injectable market: Regional movement analysis
  • Fig. 37 Aesthetic Injectable market: Regional outlook and key takeaways
  • Fig. 38 North America
  • Fig. 39 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 U.S.
  • Fig. 41 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Canada
  • Fig. 43 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Europe
  • Fig. 45 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 UK
  • Fig. 47 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Germany
  • Fig. 49 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 France
  • Fig. 51 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Italy
  • Fig. 53 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Spain
  • Fig. 55 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Denmark
  • Fig. 57 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Sweden
  • Fig. 59 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Norway
  • Fig. 61 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Asia Pacific
  • Fig. 63 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Japan
  • Fig. 65 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 China
  • Fig. 67 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 India
  • Fig. 69 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Australia
  • Fig. 71 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 South Korea
  • Fig. 73 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Thailand
  • Fig. 75 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Latin America
  • Fig. 77 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Brazil
  • Fig. 79 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Mexico
  • Fig. 81 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Argentina
  • Fig. 83 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Middle East and Africa
  • Fig. 85 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 South Africa
  • Fig. 87 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Saudi Arabia
  • Fig. 89 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 UAE
  • Fig. 91 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Kuwait
  • Fig. 93 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-275-9

Aesthetic Injectable Market Growth & Trends:

The global aesthetic injectable market size is expected to reach USD 24.13 billion by 2030, registering a CAGR of 12.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The industry is experiencing notable growth driven by several factors. These include increasing consumer awareness about minimally invasive cosmetic procedures, advancements in injectable technologies, and rising demand for non-surgical aesthetic enhancements.

Technological and research progress has led to the development of inventive injectable formulations, expanding the market's offerings to include various products addressing precise concerns like fine lines, wrinkles, volume loss, and skin texture. For instance, according to the National Center for Biotechnology and Information (NCBI) in January 2024, the injectable Sculptra Poly-L-Lactic Acid (PLLA-SCA) treatments were well received and notably diminished the severity of moderate to severe wrinkles and cheek lines while enhancing skin quality. Their effectiveness remained consistent throughout the 12-month study, with subjects reporting high satisfaction, achieving a natural appearance, and expressing eagerness for further treatments.

Additionally, shifting beauty standards and a growing aging population contribute to market expansion. Moreover, the availability of a wide range of injectable products, coupled with innovative marketing strategies by key players, further stimulates market growth. Furthermore, favorable regulatory frameworks and an expanding network of aesthetic clinics and medical spas are fostering the uptake of aesthetic injectables worldwide.

Aesthetic Injectable Market Report Highlights:

  • Based on the product, the botulinum toxin (Botox) segment accounted for the largest revenue share of 45.8% in 2023 as it is used temporarily to reduce the appearance of facial wrinkles and fine lines
  • The hyaluronic acid (HA) segment is expected to grow at the fastest CAGR of 12.7% during the forecast period as it provides the advantage of enhancing skin hydration, volume, and elasticity, resulting in a smoother and more youthful appearance
  • Based on the end-use, the medical spas segment accounted for the largest revenue share of 46.9% in 2023 and is expected to grow at the fastest CAGR of 12.3% during the forecast period. Medical spas contribute to the growth of the aesthetic injectables market by offering a range of cosmetic procedures, including injectable treatments, in a relaxing and luxurious environment
  • Based on the application, the facial line correction segment accounted for the largest revenue share of 33.4% in 2023 and is expected to grow at the fastest CAGR of 12.5% during the forecast period, as it addresses various concerns such as fine lines, wrinkles, and volume loss for facial rejuvenation
  • In 2023, North America dominated with a share of 39.3% due to the constant demand for cosmetic enhancement products and Asia Pacific is expected to grow at the fastest CAGR of 15.8% during the forecast period as this region is a hub for technological innovation, with continuous advancements in aesthetic injectables and techniques

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End use
    • 1.2.3. Application
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End use outlook
    • 2.2.3. Application outlook
  • 2.3. Competitive Insights

Chapter 3. Aesthetic Injectable Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver Analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Aesthetic Injectable Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Aesthetic Injectable Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Aesthetic Injectable Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Hyaluronic Acid (HA)
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Botulinum Toxin (Botox)
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Aquatic Light Injections
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Aesthetic Injectable Market: End Use Estimates & Trend Analysis

  • 5.1. End Use Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Aesthetic Injectable Market by End Use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Medical Spas
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Dermatology Clinics
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Hospitals
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Aesthetic Injectable Market: Application Estimates & Trend Analysis

  • 6.1. Application Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Aesthetic Injectable Market by Application Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Facial Line Correction
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Lip Augmentation
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Face Lift
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Acne Scar Treatment
      • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Lipoatrophy Treatment
      • 6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.6. Others
      • 6.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Company Profiles
    • 7.2.1. Ipsen Pharma
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. AbbVie, Inc.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Merz GmbH and Co. KGaA
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Galderma
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Prollenium Medical Technologies, Inc.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Suneva Medical, Inc.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Sinclair Pharma
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Medytox, Inc.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Revance Therapeutics, Inc.
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives